Company / Return on Assets (ROA)
Perspective Therapeutics, Inc. Return on Assets (ROA) History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-12.5%
FY2022
5-year range
-77.0% / -7.3%
FY2018-FY2022
Trend
-71.3%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -77.0% in FY2020 to -7.3% in FY2021.
Based on SEC 10-K filings.
-12.5% in FY2022 with a 5-year CAGR of +17.5%.
Improved from -77.0% to -12.5% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +52.9pp
- 5-Year Change
- +17.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2022, return on assets (roa) decreased 71.3% year-over-year.
- Peak return on assets (roa) was recorded in FY2021.
- Lowest return on assets (roa) in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2022 | -12.5% | -71.3% |
| FY2021 | -7.3% | +90.5% |
| FY2020 | -77.0% | -17.8% |
| FY2019 | -65.4% | -3.5% |
| FY2018 | -63.2% | -110.6% |
| FY2017 | -30.0% | +8.9% |
| FY2016 | -32.9% | -96.3% |
| FY2015 | -16.8% | -15.4% |
| FY2014 | -14.5% | +70.6% |
| FY2013 | -49.5% | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026